Documente Academic
Documente Profesional
Documente Cultură
Between
_________________________
and
_________________________
Approvals:
CONTRACTOR
CONTRACTEE
This agreement is intended to describe the responsibilities of both parties in the design,
manufacture, testing, packaging, control and delivery of the Product, and to ensure that
operations are in accordance with applicable United States Food and Drug Administration
(FDA) regulatory requirements. This agreement may be a supplement to an overarching
business agreement between the contractor and contractee.
This Quality Agreement is comprised of a detailed checklist of the activities associated
with manufacture of the Product. Responsibility for each activity is assigned to one or
both parties in the Responsibility Table.
2.0 PURPOSE
The purpose of this Quality Agreement is to define the responsibilities associated with the
manufacture of ______________, (hereinafter known as Product), between contractor and
contractee.
3.0 SCOPE
The scope of this agreement includes all quality/regulatory activities defined in the
Responsibility Table.
5.0 DEFINITIONS
Batch: A specific quantity of Product to be determined by the parties that is produced in a
process or series of processes that it is expected to be homogeneous within specified
requirements.
CAPA: Corrective and Preventive Action
CAPA System: A corrective and preventive action as defined in 21 CFR 210 and 211.
Certificate of Analysis (COA): A listing of all results for tests conducted on samples of
the lot of the Product compared to the specifications and listed in regulatory applications.
Certificate of Compliance (COC): A statement that the lot of Product was manufactured,
packaged and tested in accordance with cGMPs.
Contractee: The facility/organization responsible for defining expectations of the
contractor.
The following subcontractors have been approved by and may be engaged for the
activities as specified under this Agreement: